← The Wire
TARANasdaq
Protara Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · CIK 1359931
Advancing transformative cell therapies and phospholipid substrate replacement therapies for cancer and rare diseases
red 8-K · 90d
$219M
Market cap
$4.16
Last close
+1.0%
1D
+1.2%
5D
989K
Volume
Price · last 39 sessions-23.7%
May 4L $3.65 · H $5.66Jun 29
244
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
10-QQUARTERLY REPORTMay 13, 202610-QQUARTERLY REPORTNov 10, 202510-QQUARTERLY REPORTAug 11, 202510-QQUARTERLY REPORTMay 8, 202510-QQUARTERLY REPORTNov 12, 202410-QQUARTERLY REPORTAug 6, 202410-QQUARTERLY REPORTMay 2, 202410-QQUARTERLY REPORTNov 3, 202310-QQUARTERLY REPORTAug 3, 202310-QQUARTERLY REPORTMay 4, 202310-QQUARTERLY REPORTNov 3, 202210-QQUARTERLY REPORTAug 9, 202210-QQUARTERLY REPORTMay 5, 202210-QQUARTERLY REPORTNov 4, 202110-QQUARTERLY REPORTAug 5, 202110-QQUARTERLY REPORTMay 6, 202110-QQUARTERLY REPORTNov 12, 202010-QQUARTERLY REPORTJul 31, 202010-QQUARTERLY REPORTMay 13, 202010-QFORM 10-QOct 31, 201910-QFORM 10-QAug 7, 201910-QFORM 10-QMay 8, 201910-QFORM 10-QNov 7, 201810-QFORM 10-QAug 7, 201810-QFORM 10-QMay 9, 201810-QFORM 10-QNov 7, 201710-QFORM 10-QAug 7, 201710-QFORM 10-QMay 10, 201710-QFORM 10-QNov 7, 201610-QFORM 10-QAug 8, 201610-QFORM 10-QMay 9, 201610-QFORM 10-QNov 12, 201510-QFORM 10-QAug 13, 201510-QFORM 10-QMay 13, 201510-QFORM 10-QNov 25, 2014
Similar companies
Comparable business profile · signals at a glance